FIELD: pharmacology.
SUBSTANCE: antiangiogenic drug contains dimeric macrocyclic tannin isolated from shoots and inflorescences of Chamerion angustifolium, with C68H48O44 composition as an active substance, with a molecular weight of 1568.1518 of the following formula:
        
.
EFFECT: pronounced antiangiogenic and antitumour activity.
6 dwg, 1 ex
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD FOR ISOLATING THE SUM OF TANNINS USED TO OBTAIN THE SUBSTANCE OF THE ANTICANCER DRUG "HANEROL" FROM NARROW-LEAVED FIREWEED (IVAN TEA) (CHAMAENERION ANGUSTIFOLIUM (L.) SCOP.) | 2020 | 
									
  | 
                RU2750730C1 | 
| COMPLEX ANTIANGIOGENIC AND HYPOXIA-TARGETED ANTITUMOR AGENT | 2022 | 
									
  | 
                RU2804771C1 | 
| INDOLOCARBAZOLE DERIVATIVE BLOCKING TUMOUR VASCULOGENIC MIMICRY | 2014 | 
									
  | 
                RU2557554C1 | 
| TUMOUR THERAPY AGENT | 2019 | 
									
  | 
                RU2726801C1 | 
| APPLICATION OF HUMAN SKIN MELANOMA CELL LINE mel Cher AS POSITIVE MODEL OF VASCULOGENIC MIMICRY | 2009 | 
									
  | 
                RU2404243C1 | 
| COMPLEX ANTI-TUMORAL PRODUCT | 2020 | 
									
  | 
                RU2751776C2 | 
| FUSED PROTEIN WITH EFFECT OF ANGIOGENESIS INHIBITOR | 2008 | 
									
  | 
                RU2372354C1 | 
| HYDROXAMIC ACIDS, 4-AMINOQUINAZOLINE DERIVATIVES WITH ANTITUMOR ACTIVITY | 2022 | 
									
  | 
                RU2802463C1 | 
| ANTIANGIOGENIC MEDICINAL AGENT AND METHOD OF ITS PRODUCTION | 2009 | 
									
  | 
                RU2404783C1 | 
| APPLICATION OF MEDICATIONS, BINDING EDG-RECEPTOR, IN TREATMENT OF CANCER DISEASE | 2008 | 
									
  | 
                RU2426555C2 | 
Authors
Dates
2017-10-24—Published
2016-12-22—Filed